The American Society for Gastrointestinal Endoscopy recommends screening individuals with an increased risk of pancreatic cancer due to genetic susceptibility, including BRCA2 and BRCA1 gene mutations, using imaging methods—EUS, MRI, or a combination of both methods. This evidence concerns the gene BRCA1 and familial pancreatic carcinoma.